Published in Oncology Business Week, July 16th, 2006
Under the terms of the agreement, Epigenomics and the Molecular Imaging Program at Stanford (MIPS), directed by Dr. Sanjiv Sam Gambhir, will determine potential complementary benefits in the use of DNA methylation markers developed for early detection of colorectal cancer and molecular imaging (FDG PET) in detecting colorectal cancer.
Positron emission tomography (PET) is a medical imaging technique which produces a three...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.